TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis

Abstract Antibody-drug conjugates (ADCs) directed to trophoblast cell surface antigen 2 (TROP2) have gained approval as a therapeutic option for advanced triple‐negative breast cancer, and TROP2 expression has been linked to unfavourable outcomes in various malignancies. In colorectal carcinoma (CRC...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastian Foersch (Author), Maxime Schmitt (Author), Anne‐Sophie Litmeyer (Author), Markus Tschurtschenthaler (Author), Thomas Gress (Author), Detlef K Bartsch (Author), Nicole Pfarr (Author), Katja Steiger (Author), Carsten Denkert (Author), Moritz Jesinghaus (Author)
Format: Book
Published: Wiley, 2024-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items